Date:5/28/2009

l paid-in capital 42,738,000 42,686,000 Accumulated deficit (39,465,000) (39,094,000) ---------- ---------- Total shareholders' equity 4,226,000 4,545,000 --------- --------- Total liabilities and shareholders' equity $5,186,000 $5,834,000 ========= ========= See accompanying report of management. Three Months Ended April 30, VERSUS TECHNOLOGY, INC. AND SUBSIDIARY Consolidated Statements of Operations (Unaudited) Three Months Ended Six Months Ended April 30, April 30, 2009 2008 2009 2009 Revenues $1,137,000 $1,424,000 $2,750,000 $2,850,000 --------- --------- --------- --------- Operating Expenses Cost of revenues 350,000 413,000 797,000 826,000 Research and development 166,000 206,000 330,000 383,000 Sales and marketing 805,000 819,000 1,591,000 1,557,000 General and administrative 226,000 246,000 411,000 491,000 ------- ------- ------- ------- Total Operating Expenses 1,547,000 1,684,000 3,129,000 3,257,000 --------- --------- --------- --------- Loss From Operations (410,000) (260,000) (379,000) (407,000) ------- ------- ------- ------- Other Income (Expense) Interest income
'/>"/>

SOURCE Versus Technology, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. MapMyRide.com Teams Up With VERSUS for the Grand Tours Challenge
2. New Study Shows Women Experience Significantly Less Unscheduled Bleeding With the ORTHO TRI-CYCLEN(R) LO Birth Control Pill Versus Another Pill
3. Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009
4. Western Maryland Health System Selects VISion, Versus Technologys Real-Time Location System Following Competitive Bid Process
5. SPCG-4 trial: Update on watchful waiting versus radical prostatectomy
6. Versus Technology Announces First Quarter Results
7. Versus Technology, Inc. Announces Sale of Real-Time Location System to Virginia Mason Kirkland Clinic
8. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
9. Versus Technology, Inc. Announces Expansion of Real-Time Location System to Include Anesthesia Clinic at PeaceHealth RiverBend Campus
10. Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center
11. Versus Technology Announces Fiscal Year Results